Dr Reddys Laboratories Ltd is quoting at Rs 3955, down 0.47% on the day as on 13:24 IST on the NSE. The stock jumped 48.97% in last one year as compared to a 12.51% slide in NIFTY and a 22.66% spurt in the Nifty Pharma index.
Dr Reddys Laboratories Ltd is down for a fifth straight session today. The stock is quoting at Rs 3955, down 0.47% on the day as on 13:24 IST on the NSE. The benchmark NIFTY is up around 0.67% on the day, quoting at 10381.6. The Sensex is at 35169.27, up 0.59%.Dr Reddys Laboratories Ltd has added around 0.04% in last one month.Meanwhile, Nifty Pharma index of which Dr Reddys Laboratories Ltd is a constituent, has increased around 2.35% in last one month and is currently quoting at 10135.9, down 1.02% on the day. The volume in the stock stood at 3.62 lakh shares today, compared to the daily average of 9.55 lakh shares in last one month.
The benchmark July futures contract for the stock is quoting at Rs 3918.85, down 0.85% on the day. Dr Reddys Laboratories Ltd jumped 48.97% in last one year as compared to a 12.51% slide in NIFTY and a 22.66% spurt in the Nifty Pharma index.
The PE of the stock is 22.49 based on TTM earnings ending March 20.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app